Nutex Health (FRA:5LF) ROCE %: 60.21% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:5LF Nutex Health Inc FRA:5LF
57 GF Score
Price €165.00
GF Value €70.29
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Nutex Health ROCE %?

Nutex Health FRA:5LF +3.77% 57 ROCE % is 60.21% as of Jun. 2026. GuruFocus rates FRA:5LF with a GF Score™ of 57/100 and a GF Value™ of €70.29 (Significantly Overvalued). The stock has 6 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Nutex Health's annualized ROCE % for the quarter that ended in Jun. 2026 was 60.21%.

Nutex Health  (FRA:5LF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Nutex Health ROCE % Related Terms

Nutex Health ROCE % Historical Data

* Premium members only.

The historical data trend for Nutex Health's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nutex Health ROCE % Chart

Nutex Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial 57.20 -114.44 -8.84 31.36 40.43

Nutex Health Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.52 72.05 16.06 42.65 60.21
FRA:5LF
57GF Score
Nutex Health Inc FRA:5LF
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nutex Health ROCE % Calculation

Nutex Health's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=228.024/( ( (625.831 - 147.285) + (784.42 - 134.856) )/ 2 )
=228.024/( (478.546+649.564)/ 2 )
=228.024/564.055
=40.43 %

Nutex Health's ROCE % of for the quarter that ended in Jun. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Jun. 2026 )  (Q: Mar. 2026 )(Q: Jun. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Jun. 2026 )  (Q: Mar. 2026 )(Q: Jun. 2026 )
=422.736/( ( (828.08 - 159.537) + (837.298 - 101.747) )/ 2 )
=422.736/( ( 668.543 + 735.551 )/ 2 )
=422.736/702.047
=60.21 %

(1) Note: The EBIT data used here is four times the quarterly (Jun. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 60.21% mean?
Nutex Health (FRA:5LF) has a ROCE % of 60.21% as of Jun. 2026.
Is Nutex Health's ROCE % too high?
Nutex Health's current ROCE % is 60.21%. The Healthcare Providers & Services industry median ROCE % is 6.77. Nutex Health's value of 60.21% is 789.4% above this industry median. Overall, Nutex Health has a GF Score™ of 57/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nutex Health's ROCE % compare to USPH and AMN?
Nutex Health's ROCE % of 60.21% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.77. Nutex Health's value of 60.21% is 789.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.77, based on 647 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nutex Health's current ROCE % of 60.21% is 789.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nutex Health's current ROCE % is 60.21%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nutex Health stock overvalued right now?
Based on GuruFocus' analysis, Nutex Health (FRA:5LF) is currently considered Significantly Overvalued. The stock's GF Value™ is €70.29, compared to a current price of €165.00 — trading 134.7% above its estimated fair value. The current ROCE % is 60.21% and 789.4% above the Healthcare Providers & Services industry median of 6.77. Nutex Health's overall GF Score™ is 57/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Nutex Health (FRA:5LF), the current ROCE % is 60.21% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nutex Health (FRA:5LF) Overvalued in 2026?

Based on GuruFocus' analysis, Nutex Health stock appears to be overvalued. The current stock price of €165.00 is trading 134.7% above its estimated GF Value™ of €70.29. GuruFocus considers Nutex Health to be Significantly Overvalued.

Key valuation signals for FRA:5LF:

  • ROCE %: 60.21%
  • GF Value™: €70.29 vs. price of €165.00 (134.7% above fair value)
  • GF Score™: 57/100 with 6 warning signs
  • Industry Position: 789.4% above the Healthcare Providers & Services median

No single metric tells the full story. See the FRA:5LF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nutex Health Business Description

Other Exchanges NUTX:USA
Address 1776 Yorktown Street, Suite 700, Houston, TX, USA, 77056
Nutex Health Inc is a physician-led, healthcare services and operations company with various hospital facilities in the U.S. states (hospital division), and a primary care-centric, risk-bearing population health management division. The company has three segments: the hospital division, the PHM division, and the real estate division. The hospital division implements and operates health care models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management (PHM) division owns and operates provider networks such as independent physician associations (IPAs). The Real Estate Entities own the land and hospital buildings which are leased to its hospital entities. The majority of the revenue is derived from the Hospital division.
57GF Score

Get the complete analysis for FRA:5LF

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€165.00
Price
€70.29
GF Value